Raffaella Buzzetti
Endocrinology — Policlinico Umberto I, Italy
Raffaella Buzzetti
LeadR Profile
Endocrinology
Subspecialties: Biochemistry - Public Health - Cardiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2003 - 2026
Number : 284
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Modulation of circulating osteocalcin-expressing monocytes by glucagon like peptide-1 receptor agonists in type 2 diabetes: an exploratory pilot study. diabetes mellitus, glucagon-like peptide 1, pilot projects, cells, pilots, monocytes, glucagon-like peptide-1 receptor, osteocalcin, glucagon, therapeutics, metformin, glucagon-like peptides, diabetes mellitus, type 2 | Acta Diabetol | 2026 | 0 |
| Response to Comment on Amendolara et al. Distinct Interplay Between β-Cell Function and Insulin Resistance in Latent Autoimmune Diabetes in Adults Versus Type 2 Diabetes. diabetes mellitus, cells, insulin resistance, insulin, latent autoimmune diabetes in adults, diabetes mellitus, type 2 | Diabetes | 2026 | 0 |
| Glucagon-like peptide-1 receptor agonist treatment is associated with lower frequency of diabetic peripheral neuropathy and neuropathic pain in type 2 diabetes. diabetes mellitus, glucagon-like peptide 1, glucagon-like peptide-1 receptor, peripheral nervous system diseases, pain, glucagon, therapeutics, neuralgia, glucagon-like peptides, diabetes mellitus, type 2 | Pain | 2026 | 0 |
| Prediabetes: diagnostic aspects, clinical features, and emerging therapeutic opportunities, with a focus on Vitamin D. diabetes mellitus, endocrinology, vitamin d, vitamins, prediabetic state, therapeutics, diabetes mellitus, type 2 | J Endocrinol Invest | 2026 | 0 |
| Increasing incidence and clinical burden of paediatric type 1 diabetes in Italy: insights from a large administrative database. diabetes mellitus, comorbidity, incidence, prescriptions, aged, diagnosis, diabetes mellitus, type 1 | Acta Diabetol | 2026 | 0 |
Clinical Studies 11
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
3 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A study to investigate efficacy and safety of teplizumab compared with placebo in participants 1 to 25 years of age with Stage 3 Type 1 Diabetes 2024-519494-19-00 — diabetes mellitus, safety, metabolic diseases, nutritional and metabolic diseases, diabetes mellitus, type 1 | Phase 3 | Recruiting | 2025 |
| A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure 2024-514506-32-00 — heart failure, heart | Phase 3 | Not yet recruiting | 2025 |
| A clinical study to evaluate the effects of RO7795068 in participants with obesity or overweight and type 2 diabetes 2025-523106-32-00 — diabetes mellitus, safety, obesity, overweight, diabetes mellitus, type 2 | Phase 3 | Not yet recruiting | 2026 |
LeadR Networks
Main global connection map